FCPM III SERVICES B.V. Long-Term Concentrated

Location: Naarden, Netherlands

CIK: 0002013410 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $592M (100.0% shares, 0.0% debt)

Holdings (8)

NAMS NEWAMSTERDAM PHARMA COMPANY 46.0%

Value $272M Shares 10,597,181 Est. Cost $9.16 Unrealized +131.9%

DYN DYNE THERAPEUTICS INC 21.7%

Value $129M Shares 5,462,846 Est. Cost $12.58 Unrealized +135.2%

ENGN ENGENE HOLDINGS INC 10.8%

Value $64.06M Shares 9,632,561 Est. Cost $10.14 Unrealized -23.4%

BCYC BICYCLE THERAPEUTICS PLC 8.2%

Value $48.33M Shares 3,452,330 Est. Cost $18.38 Unrealized —

REPL REPLIMUNE GROUP INC 8.1%

Value $48.08M Shares 3,970,668 Est. Cost $11.59 Unrealized +4.8%

— ASTRIA THERAPEUTICS INC 4.3%

Value $25.68M Shares 2,872,537 Est. Cost $8.94 Unrealized —

— ACHILLES THERAPEUTICS PLC 0.5%

Value $2.749M Shares 2,390,050 Est. Cost $0.89 Unrealized —

ENGNW ENGENE HOLDINGS INC 0.4%

Value $2.427M Shares 2,878,148 Est. Cost $0.63 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NAMS	NEWAMSTERDAM PHARMA COMPANY	10,597,181	$272M	46.0%	$9.16	+131.9%	ORDINARY SHARES	N62509109
DYN	DYNE THERAPEUTICS INC	5,462,846	$129M	21.7%	$12.58	+135.2%	COM	26818M108
ENGN	ENGENE HOLDINGS INC	9,632,561	$64.06M	10.8%	$10.14	-23.4%	COM	29286M105
BCYC	BICYCLE THERAPEUTICS PLC	3,452,330	$48.33M	8.2%	$18.38	—	SPONSORED ADS	088786108
REPL	REPLIMUNE GROUP INC	3,970,668	$48.08M	8.1%	$11.59	+4.8%	COM	76029N106
—	ASTRIA THERAPEUTICS INC	2,872,537	$25.68M	4.3%	$8.94	—	COM	04635X102
—	ACHILLES THERAPEUTICS PLC	2,390,050	$2.749M	0.5%	$0.89	—	SPONSORED ADS	00449L102
ENGNW	ENGENE HOLDINGS INC	2,878,148	$2.427M	0.4%	$0.63	—	W EXP 10/31/2028	29286M113